Your browser doesn't support javascript.
loading
Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
Wang, Hai-Jing; Yang, Zai-Xing; Dai, Xiao-Tian; Chen, Yong-Feng; Yang, He-Ping; Zhou, Xiang-Dong.
Afiliação
  • Wang HJ; Department of Respiratory Medicine, Southwest Hospital, The Third Military Medical University, Chongqing, China.
  • Yang ZX; Department of Respiratory Medicine, Southwest Hospital, The Third Military Medical University, Chongqing, China.
  • Dai XT; Department of Respiratory Medicine, Southwest Hospital, The Third Military Medical University, Chongqing, China.
  • Chen YF; Department of Respiratory Medicine, Southwest Hospital, The Third Military Medical University, Chongqing, China.
  • Yang HP; Department of Respiratory Medicine, Southwest Hospital, The Third Military Medical University, Chongqing, China.
  • Zhou XD; Department of Respiratory Medicine, Southwest Hospital, The Third Military Medical University, Chongqing, China. cslz.fwjt@163.com.
Apoptosis ; 22(9): 1157-1168, 2017 Sep.
Article em En | MEDLINE | ID: mdl-28677094
ABSTRACT
Curcumin, a dietary supplement or herbal medicine from Curcuma longa, has shown antitumor activity in different cancer cell lines and clinical trials. CA916798, a novel protein, is overexpressed in multidrug-resistant tumor cells. This study aimed to assess the effects of curcumin on regulating chemosensitivity in cisplatin-resistant non-small cell lung cancer (NSCLC) cells in vitro and to explore the underlying molecular mechanisms. Human cisplatin-sensitive A549 and cisplatin-resistant A549/CDDP lung adenocarcinoma cells were treated with curcumin to assess cell viability and gene modulations using quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and western blotting. CA916798 shRNA and point mutations were used to assess the CA916798 functions and phosphorylation sites. Bisdemethoxycurcumin sensitized cisplatin-resistant lung cancer cells to various chemotherapeutic agents, including cisplatin. Bisdemethoxycurcumin reduced the levels of CA916798 mRNA and protein in A549 and A549/CDDP cells, while it also suppressed phosphatidylinositol-3-kinase (PI3K)/AKT signaling. CA916798, as a downstream gene, interacted with AKT after bisdemethoxycurcumin treatment in A549 and A549/CDDP cells. Moreover, A549/CDDP cells expressing the point-mutated CA916798-S20D protein were more resistant to cisplatin and bisdemethoxycurcumin, whereas tumor cells expressing CA916798-S20A, CA916798-S31A, CA916798-S60A, CA916798-S93A, or CA916798-T97A (different sites of amino acid phosphorylation) showed similar sensitivity or resistance to cisplatin and bisdemethoxycurcumin, compared with the control cells. Bisdemethoxycurcumin is able to sensitize cisplatin-resistant NSCLC cells to chemotherapeutic agents by inhibition of CA916798 and PI3K/AKT activities. Moreover, phosphorylation of CA916798 at the S20 residue plays a critical role in mediating bisdemethoxycurcumin antitumor activity.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Adenocarcinoma / Transdução de Sinais / Carcinoma Pulmonar de Células não Pequenas / Resistencia a Medicamentos Antineoplásicos / Curcumina / Neoplasias Pulmonares / Proteínas de Neoplasias Limite: Animals / Humans Idioma: En Revista: Apoptosis Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Adenocarcinoma / Transdução de Sinais / Carcinoma Pulmonar de Células não Pequenas / Resistencia a Medicamentos Antineoplásicos / Curcumina / Neoplasias Pulmonares / Proteínas de Neoplasias Limite: Animals / Humans Idioma: En Revista: Apoptosis Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China